文献速递真菌感染新发突发、热带与寄生虫病

重症冠状病毒病合并曲霉病

Aspergillosis Complicating Severe Coronavirus Disease.
PubMed 文献 · Emerg Infect Dis · 2020-10-21

本文报告20例冠状病毒病相关肺曲霉病(CAPA)病例,并综述其病理生理、诊断与结局。CAPA与经典侵袭性曲霉病不同,兼具气道侵袭和血管侵袭特征,影像学表现多样。CAPA患者预后差,亟需改进诊断、预防和治疗策略。

要点

  • CAPA兼具气道侵袭和血管侵袭,风险因素包括病毒或炎症所致上皮损伤等。
  • CAPA患者预后差,需前瞻性研究改善诊断、预防和治疗。

核心结论

  • 重症冠状病毒病合并曲霉病(CAPA)是不同于经典侵袭性曲霉病的综合征,预后差。

研究设计与样本

  • 病例系列研究,新增20例CAPA病例,并综述病理生理、诊断和结局。

主要发现

  • CAPA兼具气道侵袭和血管侵袭特征,影像学异常多样反映不同病理。
  • CAPA风险与气道真菌清除和杀灭不良相关,包括病毒或炎症相关上皮损伤、全身免疫抑制和基础肺病。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Aspergillosis complicating severe influenza infection has been increasingly detected worldwide. Recently, coronavirus disease-associated pulmonary aspergillosis (CAPA) has been detected through rapid reports, primarily from centers in Europe. We provide a case series of CAPA, adding 20 cases to the literature, with review of pathophysiology, diagnosis, and outcomes. The syndromes of pulmonary aspergillosis complicating severe viral infections are distinct from classic invasive aspergillosis, which is recognized most frequently in persons with neutropenia and in other immunocompromised persons. Combined with severe viral infection, aspergillosis comprises a constellation of airway-invasive and angio-invasive disease and results in risks associated with poor airway fungus clearance and killing, including virus- or inflammation-associated epithelial damage, systemic immunosuppression, and underlying lung disease. Radiologic abnormalities can vary, reflecting different pathologies. Prospective studies reporting poor outcomes in CAPA patients underscore the urgent need for strategies to improve diagnosis, prevention, and therapy.

来源:Emerg Infect Dis,查看原文。版权归原作者所有。

引用

  1. Marr KA, Platt A, Tornheim JA, et al. Aspergillosis Complicating Severe Coronavirus Disease. Emerg Infect Dis. 2020. PMID: 33084566. doi:10.3201/eid2701.202896

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。